VRTX
NASDAQ
US
Vertex Pharmaceuticals Incorporated - Common Stock
$438.71
▼ $-8.55
(-1.91%)
Vol 1.2M
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$115.0B
P/E
31.3
ROE
21.8%
Margin
31.4%
D/E
0.00
Beta
0.30
52W
$363–$520
Wall Street Consensus
40 analysts · Apr 202613
Strong Buy
20
Buy
6
Hold
0
Sell
1
Strong Sell
82.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $5.17 | $5.03 | $-0.14 |
| Sep 2025 | $4.65 | $4.80 | +$0.15 |
| Jun 2025 | $4.37 | $4.52 | +$0.15 |
| Mar 2025 | $4.37 | $4.06 | $-0.31 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 22.1% | 22.1% | 22.1% | 22.1% | 21.8% | 21.8% |
| P/E (TTM) | 31.43 | 28.00 | 28.76 | 30.00 | 29.90 | 31.30 |
| Net Margin | 34.8% | 31.9% | 31.9% | 31.9% | 31.4% | 31.4% |
| Gross Margin | 86.2% | 86.1% | 86.1% | 86.1% | 86.3% | 86.3% |
| D/E Ratio | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 |
| Current Ratio | 2.52 | 2.52 | 2.52 | 2.52 | 2.36 | 2.36 |
Key Ratios
ROA (TTM)
15.6%
P/S (TTM)
9.81
P/B
6.3
EPS (TTM)
$14.23
CF/Share
$13.94
Rev Growth 3Y
+13.3%
52W High
$519.68
52W Low
$362.50
$362.50
52-Week Range
$519.68
How does VRTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
VRTX valuation vs Biotechnology peers
P/E ratio
31.3
▲
67%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
9.8
▼
24%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
6.3
▲
157%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
VRTX profitability vs Biotechnology peers
ROE
21.8%
▲
132%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
31.4%
▲
111%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
86.3%
▲
10%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
15.6%
▲
133%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
VRTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.4
▼
47%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
69%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
VRTX fundamentals radar
VRTX
Peer median
Industry
VRTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VRTX vs peers: key metrics
Latest AI Opinion
ChatGPT
BUY
Price action: VRTX has pulled back from the March highs (~$486) into the $443 area and is sitting near a multi-week support zone in the $440–$460 range that has held several times over the last 3 months, so the current …
Mar 24, 2026